首页 正文

Maternal plasma syndecan-1: a biomarker for fetal growth restriction

{{output}}
Objective: The identification of fetal growth disorders is an important clinical priority given that they increase the risk of perinatal morbidity and mortality as well as long-term diseases. A subset of small-for-gestational-age... ...